Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

51.28 -0.82 (-1.57%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Meet the 2 Formerly Down-and-Out Stocks That Are Outperforming the S&P 500 This Year. Are They Still a Buy? ↗

Today 7:30 EDT

These stocks have surged in the double-digits.

Via The Motley Fool

Topics Artificial Intelligence Stocks

3 Mid-Cap Stocks We’re Skeptical Of

Today 0:34 EDT

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...

Via StockStory

Looks Like M&A Week in 3 Different Sectors ↗

April 08, 2026

Some large merger & acquisition deals that could shake up the consumer goods and the food distribution industry, plus deals in the healthcare industry.

Via The Motley Fool

You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500. ↗

April 07, 2026

Could this player be heading into a new era of growth?

Via The Motley Fool

Topics Artificial Intelligence Economy Stocks

Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

April 06, 2026

Via ACCESS Newswire

2 S&P 500 Stocks with Exciting Potential and 1 We Ignore

April 03, 2026

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...

Via StockStory

Topics Stocks

Roivant and Immunovant Solidify Market Leadership as Brepocitinib and FcRn Programs Hit Critical Clinical Milestones

April 02, 2026

The biotechnology sector witnessed a seismic shift this week as Roivant Sciences (Nasdaq: ROIV) and its subsidiary Immunovant (Nasdaq: IMVT) reported a series of clinical and regulatory updates that...

Via MarketMinute

Topics Intellectual Property

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know

April 02, 2026

What Happened? A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100% tariffs on imports of branded and pa...

Via StockStory

Topics Government Stocks World Trade

Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability

March 31, 2026

As of March 31, 2026, Moderna Inc. (NASDAQ: MRNA) finds itself at a defining historical junction. After years of being defined by a single, world-altering product—its COVID-19 vaccine—the...

Via Finterra

Topics Initial Public Offering

Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

Topics Economy Government Stocks

Stay informed with the top movers within the S&P500 index on Friday. ↗

March 27, 2026

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

March 27, 2026

Via Chartmill

Corporate Fortress: S&P 500 Defies Gravity with Fifth Consecutive Quarter of Double-Digit Growth

March 27, 2026

The American corporate engine has proven far more durable than even the most optimistic analysts predicted just a year ago. As of March 27, 2026, final results for the fourth quarter of 2025 have...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

2 Healthcare Stocks That Could Soar Over the Next 5 Years ↗

March 26, 2026

They could make important breakthroughs in their target markets.

Via The Motley Fool

Global Growth Engine: Strong Trade and Production Fundamentals Propel U.S. Markets to Historic Highs

March 25, 2026

As of March 25, 2026, the global economic landscape has shifted from the volatility of previous years into a phase of "tenuous resilience." Fueled by a significant rebound in international trade and a...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Can the "AI Supercycle" Deliver a Fourth Consecutive Double-Digit Year for the S&P 500?

March 25, 2026

As of March 25, 2026, the S&P 500 stands at a critical crossroads. After a historic three-year run that saw the benchmark index post double-digit gains in 2023, 2024, and a robust 17.9% in 2025,...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Moderna Stock is Soaring. Is It Too Late to Buy? ↗

March 25, 2026

Moderna's full pipeline may fuel long-term growth.

Via The Motley Fool

Uncover the latest developments among S&P500 stocks in today's session. ↗

March 25, 2026

Via Chartmill

2 Mooning Stocks to Target This Week and 1 We Avoid

March 23, 2026

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a...

Via StockStory

Therapeutics Stocks Q4 Teardown: Moderna (NASDAQ:MRNA) Vs The Rest

March 19, 2026

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Via StockStory

Topics Artificial Intelligence

Pfizer vs Moderna: Which Pharma Stock Has More Upside? ↗

March 19, 2026

They aren't just "pandemic stocks."

Via The Motley Fool

Topics Intellectual Property

The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery

March 16, 2026

The biotech sector has found its new North Star in 2026. As of mid-March, Moderna Inc. (NASDAQ: MRNA) has shocked Wall Street with a staggering 83% year-to-date gain, catapulting it to the upper...

Via MarketMinute

Topics Artificial Intelligence Initial Public Offering Stocks

The S&P 500's 3 Best-Performing Stocks so far in 2026 ↗

March 16, 2026

Via MarketBeat

Topics Stocks

3 Healthcare Stocks We’re Skeptical Of

March 13, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...

Via StockStory

BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier

March 10, 2026

In a watershed moment for the biotechnology sector, BioNTech SE (NASDAQ: BNTX) has reported its full-year 2025 financial results, signaling the definitive end of the COVID-19 vaccine gold rush and the...

Via MarketMinute

Which S&P500 stocks are moving on Monday? ↗

March 09, 2026

Via Chartmill

3 Unprofitable Stocks That Concern Us

March 09, 2026

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Finding...

Via StockStory

PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Via StockStory

Topics Economy

These S&P500 stocks are moving in today's session ↗

March 06, 2026

Via Chartmill

The Moderna Pivot: Analyzing the 14% Surge and the Future of mRNA Oncology

March 06, 2026

On March 6, 2026, Moderna, Inc. (NASDAQ: MRNA) remains the centerpiece of biotech conversations following a staggering 14% surge in its share price earlier this week. For a company that became a...

Via Finterra

Topics Initial Public Offering Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.